ANDREA SABOCSIK: Open Payments
NPI 1700479532 · YORK, PA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$421 in 13 payments from 10 companies in 2025. Trend: 2023 $139 · 2024 $251 · 2025 $421
Food & beverage: $421
| Company | Payments | Amount |
|---|---|---|
| BridgeBio Pharma, Inc. | 2 | $144 |
| Novo Nordisk Inc | 2 | $54 |
| AstraZeneca Pharmaceuticals LP | 2 | $49 |
| ABIOMED | 1 | $40 |
| Actelion Pharmaceuticals US, Inc. | 1 | $31 |
| Alnylam Pharmaceuticals Inc. | 1 | $29 |
| Tactile Systems Technology Inc | 1 | $24 |
| SCPHARMACEUTICALS INC. | 1 | $19 |
| Bayer Healthcare Pharmaceuticals Inc. | 1 | $19 |
| ZOLL Services LLC (A/K/A ZOLL LifeCor Corp) | 1 | $13 |
Products named: Attruby, Wegovy, OPSYNVI, WAINUA, ONPATTRO, Flexitouch Plus, FARXIGA, FUROSCIX.
Industry payments across PA — which companies pay providers there.
